Vivesto AB (VIVE) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.021x

Based on the latest financial reports, Vivesto AB (VIVE) has a cash flow conversion efficiency ratio of -0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.79 Million ≈ $-299.93K USD) by net assets (Skr133.57 Million ≈ $14.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Vivesto AB - Cash Flow Conversion Efficiency Trend (2004–2024)

This chart illustrates how Vivesto AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read VIVE total debt and obligations for a breakdown of total debt and financial obligations.

Vivesto AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vivesto AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bang Overseas Limited NSE:BANG	-0.049x
Linkage Global Inc Ordinary Shares NASDAQ:LGCB	-0.187x
Hydrofarm Holdings Group Inc NASDAQ:HYFM	0.000x
PMPG Polskie Media S.A. WAR:PGM	-0.105x
Aptorum Group Ltd Class A NASDAQ:APM	-0.039x
JPMorgan Indian Inv Trust LSE:JII	-0.006x
Masivo Silver Corp V:MASS	-10.665x
Destiny Media Technologies Inc V:DSY	0.121x

Annual Cash Flow Conversion Efficiency for Vivesto AB (2004–2024)

The table below shows the annual cash flow conversion efficiency of Vivesto AB from 2004 to 2024. For the full company profile with market capitalisation and key ratios, see VIVE market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr158.33 Million ≈ $17.04 Million	Skr-47.25 Million ≈ $-5.08 Million	-0.298x	+14.14%
2023-12-31	Skr197.80 Million ≈ $21.29 Million	Skr-68.74 Million ≈ $-7.40 Million	-0.348x	-40.46%
2022-12-31	Skr325.42 Million ≈ $35.02 Million	Skr-80.52 Million ≈ $-8.66 Million	-0.247x	+6.56%
2021-12-31	Skr549.71 Million ≈ $59.16 Million	Skr-145.56 Million ≈ $-15.67 Million	-0.265x	+11.23%
2020-12-31	Skr686.74 Million ≈ $73.90 Million	Skr-204.86 Million ≈ $-22.05 Million	-0.298x	-3460.04%
2019-12-31	Skr819.39 Million ≈ $88.18 Million	Skr-6.87 Million ≈ $-738.89K	-0.008x	+97.01%
2018-12-31	Skr424.05 Million ≈ $45.63 Million	Skr-118.84 Million ≈ $-12.79 Million	-0.280x	+21.79%
2017-12-31	Skr345.04 Million ≈ $37.13 Million	Skr-123.63 Million ≈ $-13.30 Million	-0.358x	+19.08%
2016-12-31	Skr300.37 Million ≈ $32.32 Million	Skr-133.01 Million ≈ $-14.31 Million	-0.443x	-12.69%
2015-12-31	Skr326.05 Million ≈ $35.09 Million	Skr-128.13 Million ≈ $-13.79 Million	-0.393x	-37.13%
2014-12-31	Skr375.71 Million ≈ $40.43 Million	Skr-107.67 Million ≈ $-11.59 Million	-0.287x	+7.04%
2013-12-31	Skr281.91 Million ≈ $30.34 Million	Skr-86.90 Million ≈ $-9.35 Million	-0.308x	-41.47%
2012-12-31	Skr319.15 Million ≈ $34.35 Million	Skr-69.54 Million ≈ $-7.48 Million	-0.218x	-13.63%
2011-12-31	Skr273.47 Million ≈ $29.43 Million	Skr-52.44 Million ≈ $-5.64 Million	-0.192x	+2.07%
2010-12-31	Skr294.17 Million ≈ $31.66 Million	Skr-57.60 Million ≈ $-6.20 Million	-0.196x	-147.13%
2009-12-31	Skr141.80 Million ≈ $15.26 Million	Skr-11.23 Million ≈ $-1.21 Million	-0.079x	-133.97%
2008-12-31	Skr61.21 Million ≈ $6.59 Million	Skr14.28 Million ≈ $1.54 Million	0.233x	+167864.83%
2007-12-31	Skr64.81 Million ≈ $6.97 Million	Skr9.00K ≈ $968.54	0.000x	+100.07%
2006-12-31	Skr110.30 Million ≈ $11.87 Million	Skr-22.73 Million ≈ $-2.45 Million	-0.206x	-7.71%
2005-12-31	Skr58.90 Million ≈ $6.34 Million	Skr-11.27 Million ≈ $-1.21 Million	-0.191x	-192.02%
2004-12-31	Skr31.40 Million ≈ $3.38 Million	Skr6.53 Million ≈ $702.68K	0.208x	--

About Vivesto AB

ST:VIVE Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$5.59 Million

Skr51.93 Million SEK

Market Cap Rank

#28137 Global

#629 in Sweden

Share Price

Skr0.08

Change (1 day)

+3.45%

52-Week Range

Skr0.08 - Skr0.26

All Time High

Skr10.56